Guardion Launches Second Ocular Health Formula ‘GlaucoCetin’
Guardion Health Sciences, Inc. (GHSI)
Company Research
Source: GlobeNewswire
In an IRB-approved trial conducted at the New York Eye and Ear Infirmary, the parent compound of GlaucoCetin, GlaucoHealth, designed by Robert Ritch, MD, successfully reversed mitochondrial dysfunction in patients with glaucoma. San Diego, CA, June 04, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences and technologies company that develops, formulates and distributes condition-specific medical foods and testing technologies supported by evidence-based protocols, today announced the launch of the Company’s second ocular health formula. The proprietary formula for GlaucoCetin is based on a parent compound, GlaucoHealth, which was created by Dr. Robert Ritch of the New York Eye and Ear Infirmary. GlaucoHealth was shown in an IRB-approved clinical trial to reverse mitochondrial dysfunction in the optic nerve cells of glaucoma patients. GlaucoCetin is a highly enhanced version of this parent compound.
Show less
Read more
Impact Snapshot
Event Time:
GHSI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GHSI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GHSI alerts
High impacting Guardion Health Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GHSI
News
- Guardion Health Sciences Announces Filing of Certificate of Dissolution [Yahoo! Finance]Yahoo! Finance
- Guardion Health Sciences Announces Filing of Certificate of DissolutionGlobeNewswire
- Guardion Health Sciences announces adoption of plan of dissolution and liquidation [Seeking Alpha]Seeking Alpha
- Guardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEOGlobeNewswire
GHSI
Sec Filings
- 10/11/24 - Form 25
- 10/3/24 - Form 8-K
- 9/23/24 - Form 8-K
- GHSI's page on the SEC website